In this study, we investigated changes in PON1 lactonase activity and overall PON1 status, along with metabolic, oxidative stress, and clinical indicators before and after combined treatment, including lifestyle modification, COCs, and metformin in 60 patients with PCOS and IR. Here, PON1 is linked to polycystic ovary syndrome.